跳至主要内容
临床试验/NCT01471405
NCT01471405已完成不适用

Retrospective Non-interventional Study Evaluating Treatment Adaption During a One Year Follow-up After Completion of the 2-79-52030-207 Study in a Group of Acromegalic Patients With Macroadenoma Who Received 12 Injections of Lanreotide Autogel® 120 mg

Ipsen18 个研究点 分布在 6 个国家目标入组 54 人开始时间: 2012年1月最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
发起方
Ipsen
入组人数
54
试验地点
18
主要终点
Proportion of patients maintained on medical treatment with lanreotide Autogel

研究概览

简要总结

This non-interventional retrospective study aims to describe the therapeutic procedures and modalities received by patients and the correlation to hormone status, during a one year follow up from completion of the 2-79-52030-207 study.

研究设计

研究类型
Observational
观察模型
Cohort
时间视角
Retrospective

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Completed the 2-79-52030-207 study and received 12 injections of lanreotide Autogel 120 mg, regardless of efficacy at the end of this period.
  • Subject or in case of subject's death next of kin having given their written informed consent prior to collection of the data by the sponsor (if locally required)

排除标准

  • 未提供

结局指标

主要结局

Proportion of patients maintained on medical treatment with lanreotide Autogel

时间窗: 1 year

Proportion of patients receiving other medical treatments

时间窗: 1 year

次要结局

  • Proportion of patients with at least one pituitary surgery(1 year)

研究者

发起方
Ipsen
申办方类型
Industry
责任方
Sponsor

研究点 (18)

Loading locations...

相似试验